Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Background. There is not yet an agreed adjuvant treatment for melanoma patients with American Joint Committee on Cancer stages III B and C. We report administration of an autologous melanoma vaccine to prevent disease recurrence. Patients and Methods. 126 patients received eight doses of irradiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotem, Michal, Merims, Sharon, Frank, Stephen, Hamburger, Tamar, Nissan, Aviram, Kadouri, Luna, Cohen, Jonathan, Straussman, Ravid, Eisenberg, Galit, Frankenburg, Shoshana, Carmon, Einat, Alaiyan, Bilal, Shneibaum, Shlomo, Ozge Ayyildiz, Zeynep, Isbilen, Murat, Mert Senses, Kerem, Ron, Ilan, Steinberg, Hanna, Smith, Yoav, Shiloni, Eitan, Gure, Ali Osmay, Peretz, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887652/
https://www.ncbi.nlm.nih.gov/pubmed/27294163
http://dx.doi.org/10.1155/2016/8121985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887652/
https://www.ncbi.nlm.nih.gov/pubmed/27294163
http://dx.doi.org/10.1155/2016/8121985

Ejemplares similares